[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2024 - 2030

July 2024 | 120 pages | ID: IB1681782021EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 2 Business Days

Induced Pluripotent Stem Cells Production Market Growth & Trends

The global induced pluripotent stem cells production market size is expected t%li%reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison t%li%Embryonic Stem Cells (ESCs) has offered a significant drive t%li%the market. Advantages such as n%li%stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenari%li%for market growth. In addition, the prevalence of chronic disorders is als%li%driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according t%li%the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up t%li%25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells t%li%SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed t%li%obtain the pluripotency as that of ESCs. These iPSCs are proving t%li%be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embry%li%at the blastocyte stage, which has led t%li%a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due t%li%their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set t%li%drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights
  • By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.
    • By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing t%li%the market relevance of this segment.
  • By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
  • By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.
  • By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
  • North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
1.2. Market Definitions
  1.2.1. Process
  1.2.2. Workflow
  1.2.3. Product
  1.2.4. Application
  1.2.5. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
  1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
  3.2.1. Market Driver Analysis
    3.2.1.1. Growing applications of regenerative medicine
    3.2.1.2. Technological advancements in ipsc production
  3.2.2. Market Restraint Analysis
    3.2.2.1. Stringent process control and regulatory challenges
    3.2.2.2. High cost of production
3.3. Industry Analysis Tools
  3.3.1. Porter's Five Forces Analysis
  3.3.2. PESTEL Analysis
  3.3.3. COVID-19 Impact Analysis

CHAPTER 4. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: PROCESS BUSINESS ANALYSIS

4.1. Technology Segment Dashboard
4.2. Global Induced Pluripotent Stem Cells Production Market Process, Movement Analysis
4.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Process, 2018 to 2030 (USD Million)
4.4. Manual iPSC Production Process
  4.4.1. Global Manual iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Automated iPSC Production Process
  4.5.1. Global Automated iPSC Production Process Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 5. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: WORKFLOW BUSINESS ANALYSIS

5.1. Workflow Segment Dashboard
5.2. Global Induced Pluripotent Stem Cells Production Market Workflow Movement Analysis
5.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Reprogramming
  5.4.1. Global Reprogramming Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cell Culture
  5.5.1. Global Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Cell Characterization/Analysis
  5.6.1. Global Cell Characterization/Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Engineering
  5.7.1. Global EngineeringMarket Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
  5.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 6. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: PRODUCT BUSINESS ANALYSIS

6.1. Product Segment Dashboard
6.2. Global Induced Pluripotent Stem Cells Production Market Product Movement Analysis
6.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
6.4. Instrument/Devices
  6.4.1. Global Instrument/Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Automated Platforms
  6.5.1. Global Automated Platforms Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Consumables & Kits
  6.6.1. Global Consumables & Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.2. Media
    6.6.2.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.3. Kits
    6.6.3.1. Global Kits Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  6.6.4. Others
    6.6.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Services
  6.7.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 7. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: APPLICATION BUSINESS ANALYSIS

7.1. Sample Type Segment Dashboard
7.2. Global Induced Pluripotent Stem Cells Production Market Application Movement Analysis
7.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Drug Development and Discovery
  7.4.1. Global Drug Development and Discovery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Regenerative Medicine
  7.5.1. Global Regenerative Medicine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Toxicology Studies
  7.6.1. Global Toxicology Studies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Others
  7.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 8. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: END USE BUSINESS ANALYSIS

8.1. End Use Segment Dashboard
8.2. Global Induced Pluripotent Stem Cells Production Market End Use Movement Analysis
8.3. Global Induced Pluripotent Stem Cells Production Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Research & Academic Institutes
  8.4.1. Global Research & Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Biotechnology & Pharmaceutical Companies
  8.5.1. Global Biotechnology & Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Hospitals & Clinics
  8.6.1. Global Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 9. INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PROCESS, WORKFLOW, PRODUCT, APPLICATION, & END USE

9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
  9.3.1. North America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.3.2. U.S.
    9.3.2.1. Key Country Dynamics
    9.3.2.2. Competitive Scenario
    9.3.2.3. Regulatory Framework
    9.3.2.4. U.S. Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.3.3. Canada
    9.3.3.1. Key Country Dynamics
    9.3.3.2. Competitive Scenario
    9.3.3.3. Regulatory Framework
    9.3.3.4. Canada Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.3.4. Mexico
    9.3.4.1. Key Country Dynamics
    9.3.4.2. Competitive Scenario
    9.3.4.3. Regulatory Framework
    9.3.4.4. Mexico Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Europe
  9.4.1. Europe Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.2. UK
    9.4.2.1. Key Country Dynamics
    9.4.2.2. Competitive Scenario
    9.4.2.3. Regulatory Framework
    9.4.2.4. UK Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.3. Germany
    9.4.3.1. Key Country Dynamics
    9.4.3.2. Competitive Scenario
    9.4.3.3. Regulatory Framework
    9.4.3.4. Germany Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.4. France
    9.4.4.1. Key Country Dynamics
    9.4.4.2. Competitive Scenario
    9.4.4.3. Regulatory Framework
    9.4.4.4. France Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.5. Italy
    9.4.5.1. Key Country Dynamics
    9.4.5.2. Competitive Scenario
    9.4.5.3. Regulatory Framework
    9.4.5.4. Italy Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.6. Spain
    9.4.6.1. Key Country Dynamics
    9.4.6.2. Competitive Scenario
    9.4.6.3. Regulatory Framework
    9.4.6.4. Spain Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.7. Denmark
    9.4.7.1. Key Country Dynamics
    9.4.7.2. Competitive Scenario
    9.4.7.3. Regulatory Framework
    9.4.7.4. Denmark Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.8. Sweden
    9.4.8.1. Key Country Dynamics
    9.4.8.2. Competitive Scenario
    9.4.8.3. Regulatory Framework
    9.4.8.4. Sweden Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.4.9. Norway
    9.4.9.1. Key Country Dynamics
    9.4.9.2. Competitive Scenario
    9.4.9.3. Regulatory Framework
    9.4.9.4. Norway Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Asia Pacific
  9.5.1. Asia Pacific Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.5.2. Japan
    9.5.2.1. Key Country Dynamics
    9.5.2.2. Competitive Scenario
    9.5.2.3. Regulatory Framework
    9.5.2.4. Japan Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.5.3. China
    9.5.3.1. Key Country Dynamics
    9.5.3.2. Competitive Scenario
    9.5.3.3. Regulatory Framework
    9.5.3.4. China Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.5.4. India
    9.5.4.1. Key Country Dynamics
    9.5.4.2. Competitive Scenario
    9.5.4.3. Regulatory Framework
    9.5.4.4. India Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.5.5. Australia
    9.5.5.1. Key Country Dynamics
    9.5.5.2. Competitive Scenario
    9.5.5.3. Regulatory Framework
    9.5.5.4. Australia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.5.6. Thailand
    9.5.6.1. Key Country Dynamics
    9.5.6.2. Competitive Scenario
    9.5.6.3. Regulatory Framework
    9.5.6.4. Thailand Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.5.7. South Korea
    9.5.7.1. Key Country Dynamics
    9.5.7.2. Competitive Scenario
    9.5.7.3. Regulatory Framework
    9.5.7.4. South Korea Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Latin America
  9.6.1. Latin America Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.6.2. Brazil
    9.6.2.1. Key Country Dynamics
    9.6.2.2. Competitive Scenario
    9.6.2.3. Regulatory Framework
    9.6.2.4. Brazil Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.6.3. Argentina
    9.6.3.1. Key Country Dynamics
    9.6.3.2. Competitive Scenario
    9.6.3.3. Regulatory Framework
    9.6.3.4. Argentina Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.7. MEA
  9.7.1. MEA Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.7.2. South Africa
    9.7.2.1. Key Country Dynamics
    9.7.2.2. Competitive Scenario
    9.7.2.3. Regulatory Framework
    9.7.2.4. South Africa Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.7.3. Saudi Arabia
    9.7.3.1. Key Country Dynamics
    9.7.3.2. Competitive Scenario
    9.7.3.3. Regulatory Framework
    9.7.3.4. Saudi Arabia Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.7.4. UAE
    9.7.4.1. Key Country Dynamics
    9.7.4.2. Competitive Scenario
    9.7.4.3. Regulatory Framework
    9.7.4.4. UAE Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  9.7.5. Kuwait
    9.7.5.1. Key Country Dynamics
    9.7.5.2. Competitive Scenario
    9.7.5.3. Regulatory Framework
    9.7.5.4. Kuwait Induced Pluripotent Stem Cells Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)

CHAPTER 10. COMPETITIVE LANDSCAPE

10.1. Participant Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Participant’s Overview
  10.4.1. Lonza
    10.4.1.1. Overview
    10.4.1.2. Financial Performance
    10.4.1.3. Product Benchmarking
    10.4.1.4. Strategic Initiatives
  10.4.2. Axol Bioscience Ltd.
    10.4.2.1. Overview
    10.4.2.2. Financial Performance
    10.4.2.3. Product Benchmarking
    10.4.2.4. Strategic Initiatives
  10.4.3. Evotec
    10.4.3.1. Overview
    10.4.3.2. Financial Performance
    10.4.3.3. Product Benchmarking
    10.4.3.4. Strategic Initiatives
  10.4.4. REPROCELL Inc.
    10.4.4.1. Overview
    10.4.4.2. Financial Performance
    10.4.4.3. Product Benchmarking
    10.4.4.4. Strategic Initiatives
  10.4.5. STEMCELL Technologies
    10.4.5.1. Overview
    10.4.5.2. Financial Performance
    10.4.5.3. Product Benchmarking
    10.4.5.4. Strategic Initiatives
  10.4.6. Merck KGaA
    10.4.6.1. Overview
    10.4.6.2. Financial Performance
    10.4.6.3. Product Benchmarking
    10.4.6.4. Strategic Initiatives
  10.4.7. Fate Therapeutics
    10.4.7.1. Overview
    10.4.7.2. Financial Performance
    10.4.7.3. Product Benchmarking
    10.4.7.4. Strategic Initiatives
  10.4.8. Thermo Fisher Scientific, Inc.
    10.4.8.1. Overview
    10.4.8.2. Financial Performance
    10.4.8.3. Product Benchmarking
    10.4.8.4. Strategic Initiatives
  10.4.9. Catalent, Inc
    10.4.9.1. Overview
    10.4.9.2. Financial Performance
    10.4.9.3. Product Benchmarking
    10.4.9.4. Strategic Initiatives
  10.4.10. Applied StemCells, Inc.
    10.4.10.1. Overview
    10.4.10.2. Financial Performance
    10.4.10.3. Product Benchmarking
    10.4.10.4. Strategic Initiatives

CHAPTER 11. ANALYST VIEW

LIST OF TABLES


Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 4 Global induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 5 Global induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 6 Global induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 7 Global induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 8 Global induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
Table 9 North America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 10 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 11 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 12 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 13 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 14 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 15 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 16 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 17 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 18 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 19 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 20 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 21 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 22 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 23 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 24 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 25 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 26 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 27 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 28 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 29 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 30 Europe induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 31 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 32 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 33 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 34 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 35 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 36 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 37 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 38 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 39 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 40 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 41 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 42 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 43 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 44 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 45 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 46 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 47 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 48 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 49 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 50 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 51 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 52 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 53 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 54 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 55 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 56 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 57 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 58 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 59 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 60 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 62 Denmark induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 63 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 64 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 65 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 66 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 67 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 68 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 69 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 70 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 71 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 72 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 73 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 74 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 75 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 76 Asia Pacific induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 77 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 78 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 79 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 80 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 81 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 82 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 83 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 84 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 85 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 86 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 87 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 88 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 89 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 90 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 91 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 92 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 93 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 94 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 95 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 96 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 97 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 98 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 99 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 100 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 101 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 102 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 103 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 104 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 105 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 106 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 107 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 108 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 109 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 110 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 111 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 112 Latin America induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 113 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 114 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 115 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 116 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 117 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 118 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 119 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 120 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 121 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 122 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 123 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 124 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 125 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 126 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 127 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 128 Middle East & Africa induced pluripotent stem cells production market, by country, 2018 - 2030 (USD Million)
Table 129 Middle East & Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 130 Middle East & Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 131 Middle East & Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 132 Middle East & Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 134 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 135 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 136 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 137 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 138 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 143 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 144 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 145 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 146 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 147 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 148 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 149 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
Table 150 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
Table 151 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
Table 152 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
Table 153 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
Table 154 Participant's overview
Table 155 Financial performance
Table 156 Key companies undergoing expansions
Table 157 Key companies undergoing acquisitions
Table 158 Key companies undergoing collaborations
Table 159 Key companies launching new products
Table 160 Key companies undertaking other strategies
LIST OF FIGURES


Fig. 1 Inflammatory bowel disease treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2023)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter's five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Inflammatory bowel disease treatment market: Type movement analysis
Fig. 17 Inflammatory bowel disease treatment market: Type segment dashboard
Fig. 18 Inflammatory bowel disease treatment market Type outlook: Key takeaways
Fig. 19 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Ulcerative Colitis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Inflammatory bowel disease treatment market: Drug class movement analysis
Fig. 22 Inflammatory bowel disease treatment market: Drug class segment dashboard
Fig. 23 Inflammatory bowel disease treatment market Drug class outlook: Key takeaways
Fig. 24 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Inflammatory bowel disease treatment market: Route of administration movement analysis
Fig. 32 Inflammatory bowel disease treatment market: Route of administration segment dashboard
Fig. 33 Inflammatory bowel disease treatment market Route of administration outlook: Key takeaways
Fig. 34 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Inflammatory bowel disease treatment market: Distribution channel movement analysis
Fig. 37 Inflammatory bowel disease treatment market: Distribution channel segment dashboard
Fig. 38 Inflammatory bowel disease treatment market Distribution channel outlook: Key takeaways
Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2023 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 58 UK
Fig. 59 UK inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 70 Norway
Fig. 71 Norway inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 72 Sweden
Fig. 73 Sweden inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 86 Singapore
Fig. 87 Singapore inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 88 Thailand
Fig. 89 Thailand inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 90 Latin America
Fig. 91 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 92 Brazil
Fig. 93 Brazil inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 94 Mexico
Fig. 95 Mexico inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 96 Argentina
Fig. 97 Argentina inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 98 Middle East and Africa
Fig. 99 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 100 South Africa
Fig. 101 South Africa inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 102 Saudi Arabia
Fig. 103 Saudi Arabia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 104 UAE
Fig. 105 UAE inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 106 Kuwait
Fig. 107 Kuwait inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 108 Ansoff Matrix
Fig. 109 Heat map analysis
Fig. 110 Market differentiators


More Publications